Unichem Laboratories planning to consolidate generics formulations business in US market

23 Sep 2024 Evaluate

Unichem Laboratories is planning for integration and consolidation of the generics formulations business in the US market of M/s Bayshore Pharmaceuticals LLC (wholly owned subsidiary of Company’s holding company, Ipca Laboratories) into Unichem Pharmaceuticals (USA) Inc. (company’s wholly owned subsidiary) so as to consolidate all the Ipca Group’s USA generics formulations business under one entity. The meeting of the Board of Directors of the Company scheduled to be held on September 30, 2024 to consider the same. 

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.


Unichem Lab Share Price

380.15 1.60 (0.42%)
23-Jan-2026 11:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1630.80
Dr. Reddys Lab 1242.25
Cipla 1379.00
Zydus Lifesciences 887.80
Lupin 2152.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×